YOLFTbeta
EBR Systems Inc

EBR Systems Inc

EBR · AU · Healthcare / Medical Devices

0.155AUD-0.02 (-8.82%)

Price History

Full chart

Market Stats

Previous Close0.17
Open0.17
Day Range0.155 – 0.175
52-Week Range0.235 – 1.47
Volume2.62M
Market Cap195.87M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.26
Dividend Yield0.00%
Beta0.52
50-Day Avg0.2749
200-Day Avg0.5481

About

EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization therapy (SOLVE-CRT), an investigational device exemption. The company was incorporated in 2003 and is headquartered in Sunnyvale, California.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. John Graham McCutcheon B.A., M.B.A.
  • Employees135
  • Headquarters480 Oakmead Parkway, Sunnyvale, CA, United States, 94085, Australia
  • Websitehttps://www.ebrsystemsinc.com

Leadership

  • Mr. Allan Roger Will B.S., M.S.Executive Chairman · b. 1955
  • Mr. John Graham McCutcheon B.A., M.B.A.President, CEO & Director · b. 1961
  • Mr. Gary W. Doherty B.S.Chief Financial Officer · b. 1966
  • Mr. Michael Hendricksen B.S., M.S.Chief Operating Officer · b. 1974
  • Dr. N. Parker Willis B.S., M.S., Ph.D.Chief Technology Officer · b. 1967
  • Mr. Andrew Shute B.S.Chief Corporate Development Officer · b. 1973
  • Ms. Aimee EinsteinChief Human Resources Officer
  • Dr. Spencer H. Kubo M.D.Chief Medical Officer · b. 1956
  • Ms. Pharoah GarmaChief Regulatory Officer
  • Mr. Zheng LiCompany Secretary

Financials

Income Statement

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.29M00-001.67M
Growth (%)--100.00%-----
Cost of Revenue7.07M----01.17M
Gross Profit-5.78M----0507.09K
Gross Margin-446.70%-----30.30%
Operating Expense19.61M----38.32M48.20M
Operating Income-25.39M-20.58K-22.77K-24.28M-34.55M-38.32M-47.69M
Operating Margin-1962.11%------2850.16%
EBITDA-25.18M-20.33K-22.39K-23.62M-24.66M-37.73M-47.28M
EBITDA Margin-1945.80%------2825.23%
Net Income-24.81M-25.72K-39.84K-33.09M-35.04M-20.17M-50.46M
Net Income Margin-1917.62%------3015.34%
R&D11.05M8.01K7.23K13.23M15.82M13.21M24.77M
R&D as % of Total Revenue854.22%-----1480.52%
Interest Expense0019.01M1.53M4.48M3.00M5.84M
Interest Expense % of Total Revenue0.00%-----349.04%

Balance Sheet

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets12.39M8.40M85.42M71.68M78.90M73.56M97.29M
Total Liabilities26.21M46.05M9.53M27.73M47.84M49.20M71.69M
Total Equity-13.83M-37.65M75.90M43.95M31.06M24.36M25.61M
Cash7.29M5.88M78.24M15.46M14.58M6.92M5.80M
Total Debt18.47M33.23M4.81M21.59M41.59M41.40M58.63M
Net Debt11.18M27.35M-73.44M6.13M27.01M34.48M52.83M

Cash Flow

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-21.06K-17.55K-22.15K-30.36M-32.70M-41.23M-55.05M
Investing Cash Flow-242.13-265.3-906.81K-49.35M-8.64M1.11M8.11M
Financing Cash Flow11.28K16.41K95.76M17.01M40.47M32.48M48.46M
Capital Expenditure242.13265.3912.01K730.18K354.05K273.44K3.81M
Free Cash Flow-21.30K-17.81K-934.16K-31.09M-33.05M-41.50M-58.86M
Dividends Paid--22.42M20.00M---
FCF to OCF101.15%101.51%4217.54%102.41%101.08%100.66%106.92%
Dividend Paid to FCF---2400.51%-64.34%---

Earnings

Report DateMar 24, 2025May 13, 2025Aug 12, 2025Nov 12, 2025Mar 18, 2026May 11, 2026Aug 11, 2026
EPS Estimate0.00-0.54-0.37-0.48--0.37-0.36
EPS Actual-0.03-0.30-0.30-0.30-0.30-0.38-0.35
Surprise-44.44%18.92%37.50%--2.70%2.78%
Timing-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap195.87M
Enterprise Value151.41M
Trailing P/E0.00
Forward P/E0.00
Price / Sales30.39
Price / Book1.95
EPS-0.26
Book Value0.1313
Revenue (TTM)6.45M
Gross Profit (TTM)932.00K
EBITDA-57.13M
Profit Margin0.00%
Operating Margin-621.81%
Return on Equity-102.51%
Return on Assets-28.46%
Shares Outstanding753.36M
Shares Float616.69M
Beta0.52
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%